About SK
SK Biopharmaceuticals, a prominent global pharmaceutical company, is making significant strides in both traditional drug development and digital healthcare. The company, which originated from SK Group’s new drug research and development efforts in 1993 and was spun off in 2011, has a strong focus on central nervous system (CNS) disorders, including epilepsy, and is expanding into oncology. They have successfully developed and commercialized FDA-approved drugs like Xcopri (cenobamate) for partial-onset seizures in adults and discovered Sunosi (solriamfetol) for sleep disorders.
In a strategic move to integrate AI into healthcare, SK Biopharmaceuticals recently launched Mentis Care, a joint venture with Brazilian pharmaceutical company Eurofarma. This new entity, headquartered in Toronto, Canada, aims to commercialize an AI-based epilepsy management platform. The platform will leverage SK Biopharmaceuticals’ expertise in AI-driven electroencephalography (EEG) and wearable device technologies for real-time seizure detection and prediction, offering personalized patient care and clinical decision support tools.
SK Biopharmaceuticals is also actively investing in next-generation therapeutic modalities. They are expanding their research and development into targeted protein degradation (TPD), radiopharmaceutical therapy (RPT), and cell & gene therapy (CGT), with a particular emphasis on oncology. The company has established a self-sustaining R&D model, fueled by the strong sales of Xcopri, to fund these innovative pipeline developments.
What Physicians Need to Know
For physicians, SK Biopharmaceuticals' AI tools, particularly through Mentis Care, offer the potential for real-time seizure prediction and monitoring, enabling more proactive and personalized patient care for epilepsy. The platform aims to provide clinical decision support tools and enhance communication between patients and healthcare providers, facilitating data-driven treatment planning. In the long term, their expansion into identifying and monitoring biomarkers for other neuro-psychiatric disorders could provide valuable diagnostic and management insights.
SK Biopharmaceuticals is actively pursuing collaborations and joint ventures to expand its digital healthcare ecosystem. Their joint venture Mentis Care with Eurofarma is a key example, focusing on commercializing the AI-based epilepsy management platform in North America. They are also partnering with academic institutions like Emory University School of Medicine for the development and validation of their AI models. Furthermore, collaborations with AI companies like Insilico Medicine and PhnyX Lab indicate a strategy to integrate advanced AI platforms for drug discovery and development, streamlining processes and improving efficiency.
What the Web Says
SK Biopharmaceuticals, and its U.S. subsidiary SK life science, primarily focus on central nervous system (CNS) therapies, with their epilepsy drug Xcopri being a key product. The company has faced some challenges, including an FDA warning regarding Xcopri's TV advertising. Employer reviews are mixed, with some strong negative opinions regarding management and employee well-being, particularly for SK Biotek Swords, while other reviews are more neutral or positive.
Overall: MixedStrengths
- Focus on CNS therapies and innovative drug development.
- Successful launch of epilepsy treatment Xcopri.
- Expansion of epilepsy pipeline through licensing agreements.
- Some employees report positive experiences, especially long-term contractors at certain sites.
- Offers various employee advantages such as travel allowance, tuition support, and workplace perks (SK Life Science).
- Commitment to accelerating the development of novel CNS disease therapies.
Limitations
- FDA warning regarding misleading advertising for Xcopri.
- Negative employer reviews citing poor management and disregard for employee well-being and safety (SK Biotek Swords).
- High turnover in certain departments like QC, R&D labs, and QA teams at some locations.
- Concerns about the treatment of contract staff.
- Product still evolving with occasional bugs (for CDD Vault, used by SK Biopharmaceuticals).
- Some Glassdoor reviews suggest positive feedback might be from management.
Based on reviews from: Reddit, Indeed.com, BioSpace, Fierce Pharma, BioPharma Dive, Lensa
Last updated: 2026-10-21
Videos
News, demos, and interviews about SK.
Videos load interactively. If none appear, search YouTube for SK →
Press & Coverage
Frequently Asked Questions
Related Companies
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
Avinya NeuroTech is an Indian healthcare AI company focused on revolutionizing neurological monitoring and diagnostics. They develop AI-powered neuromonitoring systems and neuro trend analytics platforms designed for critical care and remote monitoring. Their products, such as NeuroAstra EEG analysis and NeuroPaahi monitoring devices, aim to provide rapid setup and real-time insights into brain activity, enabling […]
Cercare Medical is an AI-powered healthcare company specializing in advanced perfusion imaging solutions for neurological diseases. Their software, the Cercare Medical Neurosuite, processes CT, CBCT, and MRI data to provide detailed insights into brain health. This technology goes beyond traditional perfusion imaging by integrating proprietary biomarkers that measure not only blood flow but also oxygenation, […]
Smart Soft Healthcare is a European technology company founded in 2021 as a spin-off of Smar Soft, dedicated to revolutionizing spine diagnostic and treatment through Artificial Intelligence (AI). [1, 3, 4] Their primary goal is to provide better, faster, and more cost-effective healthcare for everyone. [1, 3] The company develops AI software products for medical […]
Wave Neuroscience is a healthcare AI company that specializes in personalized brain care through non-invasive neuromodulation technology. Their approach involves analyzing brainwave activity using machine learning to guide individualized treatment plans. This technology, known as Magnetic EEG-guided Resonance Therapy (MeRT™), aims to address a wide range of neurological disorders and enhance cognitive performance without pharmaceuticals […]